Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M57,932Revenue $M20,272Net Margin (%)13.6Altman Z-Score2.2
Enterprise Value $M65,594EPS $3.6Operating Margin %18.4Piotroski F-Score8
P/E(ttm)21.5Beneish M-Score-2.8Pre-tax Margin (%)16.3Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %14.6Quick Ratio0.9Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %4.7Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow16.8y-y EBITDA Growth Rate %60.3ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %2.0PEG4.6ROE % (ttm)11.9Less Shares Outstanding y-yN
Payout Ratio %43.0Shares Outstanding M839ROIC % (ttm)9.6Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAVanguard Health Care Fund 2015-06-30 Sold Out -0.25%$58.91 - $67.14
($61.7)
$ 69.0212%Sold Out0
TEVAGeorge Soros 2015-03-31 Sold Out -3.1%$54.93 - $62.65
($58.14)
$ 69.0219%Sold Out0
TEVAVanguard Health Care Fund 2015-03-31 Reduce-0.41%$54.93 - $62.65
($58.14)
$ 69.0219%Reduce 61.47%1,896,960
TEVAFirst Eagle Investment 2015-03-31 Add0.26%$54.93 - $62.65
($58.14)
$ 69.0219%Add 71.77%4,205,481
TEVANWQ Managers 2015-03-31 Reduce-0.24%$54.93 - $62.65
($58.14)
$ 69.0219%Reduce 8.53%3,669,079
TEVADavid Dreman 2015-03-31 Reduce-0.09%$54.93 - $62.65
($58.14)
$ 69.0219%Reduce 16.44%100,133
TEVAJames Barrow 2015-03-31 Reduce-0.05%$54.93 - $62.65
($58.14)
$ 69.0219%Reduce 5.85%10,189,904
TEVAMichael Price 2015-03-31 Reduce-0.05%$54.93 - $62.65
($58.14)
$ 69.0219%Reduce 1.61%440,300
TEVARonald Muhlenkamp 2015-03-31 Add$54.93 - $62.65
($58.14)
$ 69.0219%Add 0.18%176,710
TEVAJohn Keeley 2015-03-31 Reduce$54.93 - $62.65
($58.14)
$ 69.0219%Reduce 2.95%36,835
TEVATom Gayner 2014-12-31 Sold Out -0.67%$49.86 - $58.72
($55.72)
$ 69.0224%Sold Out0
TEVAGeorge Soros 2014-12-31 Reduce-0.55%$49.86 - $58.72
($55.77)
$ 69.0224%Reduce 22.01%4,859,966
TEVANWQ Managers 2014-12-31 Reduce-0.39%$49.86 - $58.72
($55.72)
$ 69.0224%Reduce 14.62%4,011,187
TEVAMichael Price 2014-12-31 Reduce-0.36%$49.86 - $58.72
($55.77)
$ 69.0224%Reduce 10.50%447,500
TEVADavid Dreman 2014-12-31 Reduce-0.16%$49.86 - $58.72
($55.77)
$ 69.0224%Reduce 23.89%119,838
TEVAFirst Eagle Investment 2014-12-31 Add0.14%$49.86 - $58.72
($55.72)
$ 69.0224%Add 72.35%2,448,310
TEVAVanguard Health Care Fund 2014-12-31 Reduce-0.06%$49.86 - $58.72
($55.76)
$ 69.0224%Reduce 8.19%4,923,200
TEVAJames Barrow 2014-12-31 Add0.03%$49.86 - $58.72
($55.76)
$ 69.0224%Add 4.37%10,823,115
TEVAJohn Keeley 2014-12-31 Reduce-0.01%$49.86 - $58.72
($55.72)
$ 69.0224%Reduce 20.45%37,955
TEVACharles Brandes 2014-12-31 Buy $49.86 - $58.72
($55.72)
$ 69.0224%New holding3,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    Weekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA Jul 28 2015 
    Paul Tudor Jones Buys Stakes in ADP and Visa Jun 19 2015 
    KEELEY All Cap Value Fund First Quarter 2015 Commentary Jun 17 2015 
    Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
    Leon Cooperman's Top Holdings Look Attractive Jun 09 2015 
    Actavis Stock – A Must Have For Long-Term Investors May 27 2015 
    Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
    Stanley Druckenmiller's Top 5 New Stocks May 25 2015 
    Teva Puts Forth Its Best Bid To Acquire Mylan Apr 25 2015 
    Teva Eyeing Mylan For $40 Billion Apr 23 2015 

    More From Other Websites
    Will Teva (TEVA) Stock be Helped by New Financing Commitment? Jul 31 2015
    Teva Secures $33.75 Billion Financing Commitment Jul 31 2015
    Teva Proves Its Decade-Hold Status With Massive Funding Jul 31 2015
    Teva Secures $33.75 Billion Financing Commitment Jul 31 2015
    1:22 pm Teva Pharma secures a $33.75 billion financing commitment for its acquisition of Allergan's... Jul 31 2015
    Israel ETFs Surge on Teva Megamerger Deal (revised) - ETF News And Commentary Jul 31 2015
    Teva's Q2 Earnings & Revenues Beat Expectations, View Up - Analyst Blog Jul 31 2015
    Amgen hikes 2015 forecast after 2Q increase in profit, sales Jul 30 2015
    Amgen hikes 2015 forecast after 2Q increase in profit, sales Jul 30 2015
    Teva Pharmaceutical (TEVA) Earnings Report: Q2 2015 Conference Call Transcript Jul 30 2015
    Former Teva Employee Blames Firing on Helping Feds With Bribery Probe Jul 30 2015
    NBIX: Three More Data Readouts Coming in the Second Half of 2015… Jul 30 2015
    Are Teva Earnings Enough? Jul 30 2015
    Teva's MS drug Copaxone has strong second-quarter sales Jul 30 2015
    Teva (TEVA) Beats on 2Q Earnings & Revenues, Raises Outlook - Tale of the Tape Jul 30 2015
    An ETF Chock Full of Pharma Takeover Candidates Jul 30 2015
    Teva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year 2015 Jul 30 2015
    Teva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year 2015 Jul 30 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK